Recruiting
Phase 2

Repeat BCG Vaccinations for the Treatment of Pediatric Type 1 Diabetes

Sponsor:

Massachusetts General Hospital

Code:

NCT05180591

Conditions

Diabetes Mellitus, Type 1

Diabetes Type1

Autoimmune Diabetes

Eligibility Criteria

Sex: All

Age: 12 - 17

Healthy Volunteers: Not accepted

Interventions

Bacillus Calmette-Guérin

Saline Injection

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2025-03-30. This information was provided to ClinicalTrials.gov by Massachusetts General Hospital on 2024-11-21.